MoneyWorks4Me

Kerala Ayurveda - Quaterly Results

14 Aug 2024 Evaluate
The revenue declined to Rs. 153.96 millions for the quarter ended June 2024 as compared to Rs. 158.64 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2024 is Rs. -12.94 millions as compared to Net Profit of Rs. 2.06 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -11.31% as compared to 18.61% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 153.96 158.64 -2.95 153.96 158.64 -2.95 676.21 591.24 14.37
Other Income 2.74 0.60 356.67 2.74 0.60 356.67 5.80 0.60 866.67
PBIDT -11.31 18.61 -160.77 -11.31 18.61 -160.77 50.23 46.19 8.75
Interest 4.00 13.95 -71.33 4.00 13.95 -71.33 38.27 44.41 -13.83
PBDT -15.31 4.66 -428.54 -15.31 4.66 -428.54 11.96 30.13 -60.31
Depreciation 1.94 1.91 1.57 1.94 1.91 1.57 7.68 6.39 20.19
PBT -17.25 2.75 -727.27 -17.25 2.75 -727.27 4.28 23.74 -81.97
TAX -4.31 0.69 -724.64 -4.31 0.69 -724.64 6.98 -5.18 -234.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -12.94 2.06 -728.16 -12.94 2.06 -728.16 -2.70 28.92 -109.34
Equity 120.32 105.56 13.98 120.32 105.56 13.98 120.32 105.56 13.98
PBIDTM(%) -7.35 11.73 -162.62 -7.35 11.73 -162.62 6.91 7.30 -5.35
Peers
Company Name CMP
Sun Pharma. Inds. 1769.10
Dr. Reddys Labs. 1239.65
Cipla 1330.00
Lupin 1960.00
Zydus Lifesciences 1131.00
View more..